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Myxoﬁbrosarcoma  occurs  frequently  in  the  extremities  of  older  individuals  and  is rarely  reported  in
the  head  and  neck  sites.  The  present  case  is  a rare  clinical  presentation  with  respect  to site,  size andccepted 23 July 2014
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origin  of the tumour.  Occurring  at an intraoral  site,  the  tumour  was  8 cm × 7  cm × 5.5  cm  in  dimensions.
Myxoﬁbrosarcoma is  known  to originate  from  subcutaneous  tissues  in  the  majority  of  the  cases.  The
origin  of  the tumour  was  ambiguous  in the current  case,  as  it appeared  entirely  intraorally.
The  tumour  was  resected  with adequate  margin  and  following  which  post-operative  adjuvant  radio-
therapy  was  given.
©  2014  Japanese  Stomatological  Society.  Published  by Elsevier  Ltd.  All  rights  reserved.ingivobuccal sulcus
. Introduction
Sarcomas of head and neck are rare and constitute <1% of head
nd neck malignancies [1]; among them, only 2% of head and neck
arcomas are described to occur in the oral cavity [2].
Osteosarcomas, rhabdomyosarcomas, undifferentiated pleo-
orphic sarcomas (malignant ﬁbrous histiocytomas), ﬁbrosarco-
as and angiosarcomas are among the most common histological
ypes of sarcoma found in the head and neck [3].
Myxoﬁbrosarcoma (MFS) occurs frequently in the extremities
ut is rare in the head and neck region. Cases described among the
ites of involvement in the head and neck include larynx, hypophar-
nx, infratemporal fossa, mandible, maxillary sinus, sphenoid sinus
nd parotid. Commonly occurring in older adults between the sixth
nd eighth decades of life, they are rare below the age of 20 years
4–7].
MFS also known as ‘myxoid malignant ﬁbrous histiocytoma’ is
ot classiﬁed among ﬁbrous histiocytomas; it is classiﬁed under
alignant tumours of myoﬁbroblastic origin. In two thirds of the
ases, the tumours originate from the dermal/subcutaneous tissues,
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[4].
Here, the authors present a high-grade MFS  of lower gingivobuc-
cal sulcus (GBS).
2.  Case presentation
A  28-year-old man  presented with a 4-month history of swelling
in the oral cavity (Fig. 1) with progressive painless increase in the
size of the lesion. No history of tobacco or betel nut consumption
was recorded. Clinical examination revealed a smooth, lobulated
mass in the left lower GBS, extending from the distal aspect of
the third molar until the mesial aspect of the ﬁrst premolar ipsi-
laterally and superiorly extending to the mucogingival junction
falling short of it by 1 cm.  The paramandibular extension of the
lesion was  palpable with extension into the lingual aspect of the
mandible; 3 cm × 3 cm of the skin of the cheek was inseparable
over the tumour. Further, cervical lymph nodes were palpable and
enlarged but not adherent to the surrounding tissues. There were no
systemic symptoms; metastatic screening was negative for distant
metastasis. Magnetic resonance imaging (MRI) revealed a well-
deﬁned soft tissue mass in the left lower GBS with a paramandibular
extension extending from the canine to the ramus of the mandible
(Figs. 2 and 3).
It  was  diagnosed as ‘low-grade sarcoma’ on incision biopsy.
Resection of the entire tumour was  performed along with the
skin of the cheek inseparable from the tumour. A segment of the
eserved.
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(Fig. 5); areas of necrosis and blood vessels of varying calibre
with perivascular concentration of tumour cells were observedFig. 1. Clinical photograph illustrating intraoral involvement of the tumour.
andible from the mesial aspect of the tumour to the condyle was
esected with the tumour; level I–III lymph node clearance was
one. Reconstruction of the oral mucosa was performed with a
ectoralis major myocutaneous ﬂap and the skin with transposi-
ion of the cervico-facial ﬂap. However, osseous reconstruction for
andible was not carried out.
Macroscopic evaluation of excision specimen showed a large
ultinodular grey brown tumour arising from the GBS measuring
Fig. 2. MRI Illustrating the extent o
Fig. 3. MRI  illustrating the extent ofFig. 4. Resection specimen.
8 cm × 7 cm × 5.5 cm (Fig. 4); the tumour appeared to arise from
GBS.
Microscopic ﬁndings revealed squamous mucosa incorporat-
ing a relatively cellular lesion consisting of diffuse proliferation of
plump stellate tumour cells in a stroma showing loose oedematous
appearance with focal myxoid change; there were areas of hypocel-
lularity and hypercellularity with a few pseudolipoblast-like cells(Fig. 6). The tumour showed vague nodular architecture (Fig. 7)
with tumour cells showing spindly vesicular nuclei; there was mild
f the tumour (axial section).
 the tumour (coronal section).
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Fig. 5. H&E image of tumour at 4× showing hypocellular and hypercellular areas.
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tig. 6. H&E image of tumour at 4× magniﬁcation showing areas of necrosis and
erivascular  concentration of tumour cells.
o moderate nuclear atypia of tumour cells along with the mitotic
gures (Fig. 8).These  features suggested high-grade myxoid sarcoma. Further,
mmunohistochemistry (IHC) for S100, SMA, CD68 and desmin was
egative.
ig. 7. H&E image of tumour at 10× magniﬁcation showing vague nodular archi-
ecture.Fig. 8. H&E image of tumour at 40× magniﬁcation showing mitotic ﬁgures.
The tumour was  seen to inﬁltrate into the subcutis; however,
the skin was  free. All margins were free of the tumour. There
was no evidence of osteoid production in the multiple sections
studied.
Therefore, the overall morphological features and IHC proﬁle
were suggestive of a high-grade MFS.
A total of 30 cervical lymph nodes showing reactive changes
without evidence of metastasis indicated the stage to be T4aN0M0
(AJCC 2002).
The  patient underwent adjuvant radiotherapy and is currently
under follow-up since 6 months.
3. Discussion
MFS  comprises a spectrum of malignant ﬁbroblastic lesions with
variably myxoid stroma, pleomorphism and with a distinctively
curvilinear vascular pattern of blood vessels, often with predilec-
tion to males [4]. MFS  consists of three to four grades based on the
degree of cellularity, nuclear pleomorphism and mitotic activity.
Surgery  is the main treatment modality; however, recurrences
have been described up to 57% in MFS  patients. Multivariate anal-
ysis by Huang et al. [5]. indicated a signiﬁcant risk of metastatic
relapse in tumours with necrosis or in tumours exceeding 5 cm in
size. The disease-speciﬁc mortality rate was  signiﬁcantly related
to tumour necrosis, large size and decreased myxoid area. Further
local recurrence was  shown to be 57% and among recurrent cases;
42% progressed to distant metastasis. The 5-year recurrence-free
survival and metastasis-free survival were 41% and 90%, respec-
tively.
Recently, Sanﬁlippo et al. [6]. reviewed 120 cases of primary MFS
and reported 38 patients with local recurrence. Margin status was
the only prognostic factor statistically signiﬁcant for local relapse,
while size and grade were statistically signiﬁcant predictors for
survival. Post-operative radiotherapy did not appear to improve
survival.
The current patient presented with a tumour size >5 cm and
high-grade histology – both poor prognostic factors. However, ade-
quate and tumour free margins with adjuvant radio-therapy might
address loco-regional disease control.
Mentzel et al. [7] reviewed the clinicopathological status of
75 patients with MFS  with an average period of follow-up of 45
months. Local recurrence was  reported in 33 (54%) patients. Thir-
teen patients who died had presented with intermediate- and
high-grade neoplasms that later metastasized. The authors empha-
sized the independence of histologic grade for ‘local recurrence’;
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ather, they observed a higher frequency of metastasis in patients
ith intermediate- and high-graded tumours resulting in death
mong those individuals.
The  microscopic appearance of these tumours showed
broblast-like, histiocyte-like, and myoﬁbroblast-like cells and
ultinucleated giant cells which lead to its description as ‘myxoid
alignant ﬁbrous histiocytoma’ previously; however, ultrastruc-
ural features were of a ﬁbroblastic differentiation, and histiocytic
arkers (CD68, Mac  387 and FXIIIa) were negative in MFS; thus,
hey were classiﬁed as malignant ﬁbroblastic or myoﬁbroblastic
umours in the World Health Organization (WHO) classiﬁcation
evised in 2013 [8]. Immunohistochemical staining and ultra-
tructural analysis will assist in differential diagnosis between
FS and ﬁbromyxoid sarcomas [9]. The current case was  neg-
tive for S100, SMA, CD68 and desmin which suggested the
iagnosis of MFS. MUC4 is known to be a sensitive and speciﬁc
arker for low-grade ﬁbromyxoid sarcoma (LGFMS) [10]. How-
ver, considering the high-grade status of the tumour (necrosis
ith numerous mitotic ﬁgures and signiﬁcant nuclear atypia),
GFMS was not considered in the differential diagnosis of the pre-
ented case.
These  tumours have been shown to be associated with complex
enomic proﬁles (complex karyotypes), with addition and dele-
ion of chromosomes or chromosome regions [11]. Birgit Lohberger
t al. have claimed that a cell line of MFS  (MUG-Myx1) is useful in
roviding comprehensive genetic and epigenetic characterization
12]. Further research is required in studying this entity for better
anagement through targeted therapy.
MFS occurs rarely in the head and neck. Unlike the extremi-
ies, the anatomy of the head and neck is complex, and difﬁculty
n obtaining adequate clear tumour margin can compromise prog-
osis. Hence, the patient needs to be closely followed up for
dentiﬁcation of metastasis and recurrence. This patient is one of
hose rare cases occurring in a young individual with an intra-
ral presentation and size >5 cm in greatest dimension. The origin
f this tumour is ambiguous as it appeared entirely intraorally;
hough the subcutaneous tissue was involved, skin ulceration or its
[
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microscopic involvement was  absent suggesting that it might not
have originated from the subcutaneous tissue.
4. Conclusion
MFS  occurs rarely in the head and neck region with a minority
of them presenting as intraoral mucosal swellings. The high-
grade nature and size of the tumour were unfavourable factors
in this case; however, adequate management of this patient
through tumour-free surgical resection margins and adjuvant post-
operative radiotherapy might address disease appropriately.
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